June 2016 Vol XL Issue 6
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #152
Hyperinsulinemic Hypoglycemia After Gastric Bypass SurgeryHypoglycemia after Roux-en-Y gastric bypass (RGBP) is a rare, yet challenging condition. The optimal treatment of these patients has not been well studied and the underlying etiology requires further research. The goal of this paper is to provide a practical approach to the evaluation and management of the patient who presents with hypoglycemia after RGBP.
COLORECTAL CANCER: REAL PROGRESS IN DIAGNOSIS AND TREATMENT, SERIES #4
Integrative Genomic Approaches for Evolving Personalized Colorectal Cancer TherapyIncreasingly the molecular characterization of tumors is playing a crucial role in the diagnosis and treatment of Colorectal Cancer (CRC). The focus of this review is on the state of the art clinical genomic testing of CRCs and the implications of this type of testing for developing individualized treatment strategies.
GASTROINTESTINAL MOTILITY AND FUNCTIONAL BOWEL DISORDERS, SERIES #17
Intestinal Angioedema An Often Misdiagnosed EntityIn this article, we aim to heighten the awareness of intestinal angioedema among gastroenterologists as well as help differentiate it from other more common similar gastrointestinal conditions. We review the pertinent literature and provide guidelines which could assist in the timely diagnosis and treatment of this condition.
A CASE REPORT
Fixing A Rare Complication-Broncho-Esophageal Fistula from Squamous Cell CarcinomaDepartments Section
RESEARCH COLLABORATION IDENTIFIES SERUM BIOMARKERS THAT PREDICT PRE-CLINICAL IBD DEVELOPMENT AND COMPLICATIONS
NEW YORK, NY - Years before inflammatory bowel disease (IBD) is diagnosed and symptoms exist, biomarkers are already circulating that can help predict risk not only of disease development but also of complications, according to research published online, which will also appear in the June 15th print issue of Alimentary Pharmacology & Therapeutics.